Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
Yohannes Tsegyie Wondmkun Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, EthiopiaCorrespondence: Yohannes Tsegyie Wondmkun Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health S...
Guardado en:
Autor principal: | Wondmkun YT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b4a6202929514210bc2a00f9afdc63dc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Role of JNk Signaling Pathway in Obesity-Driven Insulin Resistance
por: Feng J, et al.
Publicado: (2020) -
Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
por: Schwartz S
Publicado: (2010) -
Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients
por: Zhou X, et al.
Publicado: (2021) -
The Association Between Insulin Resistance, Leptin, and Resistin and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients with Different Body Mass Indexes
por: Huang J, et al.
Publicado: (2021) -
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017)